# Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups

> **NCT01654809** · PHASE4 · COMPLETED · sponsor: **Beijing Center for Disease Control and Prevention** · enrollment: 900 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** evaluated vaccine
- **BIOLOGICAL:** imported compared vaccine
- **BIOLOGICAL:** domestic compared vaccine

## Key facts

- **NCT ID:** NCT01654809
- **Lead sponsor:** Beijing Center for Disease Control and Prevention
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-02
- **Final completion:** 2011-06
- **Target enrollment:** 900 (ACTUAL)
- **Last updated:** 2012-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01654809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01654809, "Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01654809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*